/ /

  • linkedin
  • Increase Font
  • Sharebar

    10 ophthalmic news stories you might have missed this week


    3. Clearside Biomedical appoints Richard J. Croarkin to the Board of Directors

    Before joining the developer of first-in-class drug therapies to treat blinding diseases of the eye, Croarkin was previously the chief financial officer (CFO) of Nestlé Health Science SA, a division of Nestlé that aims to find medical nutrition solutions to chronic medical conditions. He is a director on the Board of Aerie Pharmaceuticals Inc., and is a panelist on the NASDAQ Listing Qualifications Panel.

    Jolie Higazi
    Jolie is the Content Specialist for Ophthalmology Times. She can be reached at [email protected]

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results